Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$96.57 USD
-1.34 (-1.36%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $96.58 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
GILD 96.57 -1.34(-1.36%)
Will GILD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GILD
Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook
Markets Tear Off the Lid in Hump-Day Trading
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say
Gilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates
Pre-Markets Soar after Trump Wins U.S. Presidential Election
Other News for GILD
14 out of 18 healthcare companies beat profit estimates this week- Earnings scorecard
Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon
Gilead price target raised to $95 from $85 at TD Cowen
Gilead price target raised to $97 from $83 at Truist
Gilead price target raised by $14 at Truist, here's why